![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PTCHD1-AS |
Gene summary for PTCHD1-AS |
![]() |
Gene information | Species | Human | Gene symbol | PTCHD1-AS | Gene ID | 100873065 |
Gene name | PTCHD1 antisense RNA (head to head) | |
Gene Alias | DDX53-AS1 | |
Cytomap | Xp22.11 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
100873065 | PTCHD1-AS | TD9 | Human | Lung | IAC | 2.13e-03 | 7.26e-01 | 0.088 |
100873065 | PTCHD1-AS | RNA-P10T2-P10T2-1 | Human | Lung | AAH | 4.97e-07 | 1.06e+00 | -0.1271 |
100873065 | PTCHD1-AS | RNA-P10T2-P10T2-2 | Human | Lung | AAH | 7.31e-03 | 6.74e-01 | -0.1406 |
100873065 | PTCHD1-AS | RNA-P10T2-P10T2-3 | Human | Lung | AAH | 5.95e-04 | 6.76e-01 | -0.1408 |
100873065 | PTCHD1-AS | RNA-P10T2-P10T2-4 | Human | Lung | AAH | 5.54e-03 | 7.39e-01 | -0.138 |
100873065 | PTCHD1-AS | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 1.28e-24 | 1.33e+00 | -0.2116 |
100873065 | PTCHD1-AS | RNA-P25T1-P25T1-2 | Human | Lung | AIS | 6.92e-13 | 1.20e+00 | -0.1941 |
100873065 | PTCHD1-AS | RNA-P25T1-P25T1-3 | Human | Lung | AIS | 1.24e-19 | 1.37e+00 | -0.2107 |
100873065 | PTCHD1-AS | RNA-P25T1-P25T1-4 | Human | Lung | AIS | 1.21e-28 | 1.37e+00 | -0.2119 |
100873065 | PTCHD1-AS | RNA-P8T2-P8T2-1 | Human | Lung | AIS | 1.39e-07 | 1.29e+00 | -0.1263 |
100873065 | PTCHD1-AS | RNA-P8T2-P8T2-3 | Human | Lung | AIS | 2.66e-09 | 1.33e+00 | -0.1284 |
100873065 | PTCHD1-AS | RNA-P8T2-P8T2-4 | Human | Lung | AIS | 1.48e-05 | 1.28e+00 | -0.1197 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Liver | Cyst | ![]() |
Lung | IAC | ![]() |
Lung | AIS | ![]() |
Lung | AAH | ![]() |
Lung | MIAC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |